EP3849977
IMPROVED METHOD FOR THE MANUFACTURE OF 3-[(1S)-1-IMIDAZO[1,2-A]PYRIDIN-6-YLETHYL]-5-(1-METHYLPYRAZOL-4-YL)TRIAZOLO[4,5-B]PYRAZINE AND POLYMORPHIC FORMS THEREOF
:
EP einkaleyfi: Þýðing ekki lögð inn:
10.9.2019:
19.7.2023:
19769738.6
:
9.9.2039
:
IMPROVED METHOD FOR THE MANUFACTURE OF 3-[(1S)-1-IMIDAZO[1,2-A]PYRIDIN-6-YLETHYL]-5-(1-METHYLPYRAZOL-4-YL)TRIAZOLO[4,5-B]PYRAZINE AND POLYMORPHIC FORMS THEREOF
10.9.2019
19.7.2023
:
Astrazeneca AB:
151 85 Södertälje, SE
:
Hutchison Medipharma Limited:
Building 4 720 Cai Lun Road Pilot Free Zone, Shanghai 201203, CN
:
TURNER, Andrew, Roy:
Macclesfield Cheshire SK10 2NA, GB
:
TURNER, Andrew, Timothy:
Macclesfield Cheshire SK10 2NA, GB
:
HOWELL, Gareth, Paul:
Macclesfield Cheshire SK10 2NA, GB
:
GALL, Malcolm, Allan, Young:
Macclesfield Cheshire SK10 2NA, GB
:
MULHOLLAND, Keith, Raymond:
Macclesfield Cheshire SK10 2NA, GB
:
ADLINGTON, Neil, Keith:
Macclesfield Cheshire SK10 2NA, GB
:
TIAN, Zhenping:
Jinan, Shandong 250100, CN
:
LIU, Bo:
Shanghai 201203, CN
:
GONG, Qisun:
Shanghai 201203, CN
:
YU, Wei:
Shanghai 201203, CN
:
PCT/CN2018/104941:
11.9.2018:
WO
:
EP2019074083:
10.9.2019
:
C07D 471/04, C07D 519/00